Dr. Falk Pharma International focuses on the development and distribution of innovative medicines that improve patients' health and well-being, specifically for inflammatory bowel disease and digestive and metabolic problems. self-described as experts in digestive and metabolic medicine.

Dr. Falk Pharma International

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Maps

DoubleClick.Net

US Privacy User Signal Mechanism

reCAPTCHA

Apache

Risk, Safety, Compliance

Daniela Dietz

Healthcare

Elli Nars

Engineering

M. Ercument Balta

Herbert Falk

Founder

Germany Companies (Top 10K)

Germany Companies With Less Than $1B in Revenue (Top 10K)

Biotechnology Companies With More Than 100 Employees

Health Care Companies With More Than 100 Employees (Top 10K)

Dr. Falk Pharma GmbH is an independent family firm. Their company specializes in the development and sales of medication for indications in hepatology and gastroenterology. These, mainly prescription drugs, are sold not only in Germany but also in a further 65 countries, often in co-operation with local partners but in some cases also via their own subsidiary companies

Freiburg Im Breisgau

Baden-Wurttemberg

Germany

Europe

Dr. Falk Pharma

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute...

Global Portal Hypertension Management Industry is set to ...

Nonalcoholic Steatohepatitis (NASH) Market to Observe ...

Primary Sclerosing Cholangitis Market to Grow at a ...

Termination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma

ANTI-CD30L ANTIBODIES AND USES OF THESE

Pharmaceutical formulation for the treatment of inflammatory changes to the …

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis

Systemic formulation of a pyridinone derivative for celiac disease

Switzerland

France

Côte d'Ivoire

Africa

United States

North America

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:46 PM	91978e51
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:46 PM	6cc83589
crunchbase trigger	general	Nov 4, 2024 10:53 AM	546d96ff
crunchbase profile	general	Nov 5, 2024 12:49 AM	f7d4221c
li profile	general
translate crunchbase fundingrounds	general	Nov 5, 2024 1:56 AM	76e91998
peers	general	Sep 27, 2024 4:46 PM	62db94d4
news basic	general	Sep 27, 2024 4:46 PM	19360a60
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:DRFALKPHARMA

Dr. Falk Pharma International